Bryon D. Johnson

Bryon D Johnson, R. Orentas, Weiqing Jing, 2007, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Absence of regulatory T-cell control of TH1 and TH17 cells is responsible for the autoimmune-mediated pathology in chronic graft-versus-host disease.

R. Komorowski, W. Drobyski, Xiao Chen, 2007, Blood.

Donor chimerism and immune reconstitution following haploidentical transplantation in sickle cell disease

Bryon D Johnson, J. Verbsky, M. Cairo, 2022, Frontiers in Immunology.

An updated single center experience with plerixafor and granulocyte colony‐stimulating factor for stem cell mobilization in light chain amyloidosis

P. Hari, Bryon D Johnson, A. Szabo, 2019, Journal of clinical apheresis.

STING Activated Tumor-Intrinsic Type I Interferon Signaling Promotes CXCR3 Dependent Antitumor Immunity in Pancreatic Cancer

Bryon D Johnson, M. Riese, M. Dwinell, 2021, Cellular and molecular gastroenterology and hepatology.

Experimental Animal Models in the Study of GVL Reactions

R. Truitt, R. Korngold, B. Blazar, 2000 .

Photochemical treatment of donor lymphocytes inhibited their ability to facilitate donor engraftment or increase donor chimerism after nonmyeloablative conditioning or establishment of mixed chimerism.

J. Hearst, B. Blazar, P. Taylor, 2002, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Allogeneic Bone Marrow Naive or Primed T Lymphocytes In Vivo ofand Ultraviolet A Light to Control the Fate Photochemical Treatment with S-59 Psoralen

J. Hearst, R. Truitt, S. Talib, 1999 .

Tocilizumab, tacrolimus and methotrexate for the prevention of acute graft-versus-host disease: low incidence of lower gastrointestinal tract disease

P. Hari, M. Pasquini, M. Horowitz, 2018, Haematologica.

Graft-versus-leukemia and graft-versus-host reactions after donor lymphocyte infusion are initiated by host-type antigen-presenting cells and regulated by regulatory T cells in early and long-term chimeras.

Bryon D Johnson, R. Truitt, G. Xia, 2006, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

CD25+ immunoregulatory T-cells of donor origin suppress alloreactivity after BMT.

Bryon D Johnson, M. Konkol, R. Truitt, 2002, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Utilization and cost implications of hematopoietic progenitor cells stored for a future salvage autologous transplantation or stem cell boost in myeloma patients.

P. Hari, M. Pasquini, Bryon D Johnson, 2020, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Hematopoietic Stem Cell Transplantation and Lymphodepletion for the Treatment of Cancer

Bryon D Johnson, J. Gershan, Kristen M. Barr, 2020, Cancer Immunology.

Therapeutic expression of the platelet-specific integrin, αIIbβ3, in a murine model for Glanzmann thrombasthenia

R. Hynes, Juan Fang, G. White, 2005 .

CD200 is a novel p53-target gene involved in apoptosis-associated immune tolerance.

Gordon Sandford, Edit Olasz, M. Rosenblum, 2004, Blood.

Annexin-V promotes anti-tumor immunity and inhibits neuroblastoma growth in vivo

Michael P. Krein, M. Krein, Xiaocai Yan, 2012, Cancer Immunology, Immunotherapy.

The T cell activation marker CD150 can be used to identify alloantigen-activated CD4(+)25+ regulatory T cells.

Bryon D Johnson, M. Konkol, R. Truitt, 2004, Cellular immunology.

Pathogen boosted adoptive cell transfer immunotherapy to treat solid tumors

David M. Schauder, Nikhil S. Joshi, Bryon D Johnson, 2017, Proceedings of the National Academy of Sciences.

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one

Charles J. Vaske, Rohan N. Borkar, Brian D. Kelly, 2016, Journal of Immunotherapy for Cancer.

Long‐term outcomes and predictors of early response, late relapse, and survival for patients treated with bispecific LV20.19 CAR T‐cells

P. Hari, Bryon D Johnson, A. Szabo, 2022, American journal of hematology.

CD25+ Regulatory T Cell Inhibition Enhances Vaccine-induced Immunity to Neuroblastoma

Bryon D Johnson, R. Orentas, Weiqing Jing, 2007, Journal of immunotherapy.

Induction of a VLA-2 (CD49b)-Expressing Effector T Cell Population by a Cell-Based Neuroblastoma Vaccine Expressing CD137L1

Bryon D Johnson, R. Orentas, Xiaocai Yan, 2008, The Journal of Immunology.

Early expression of stem cell-associated genes within the CD8 compartment after treatment with a tumor vaccine.

J. Khan, Qingrong Chen, R. Orentas, 2010, Cellular immunology.

Treatment-Emergent Tumor Lysis Syndrome With PI3Kδ-γ Inhibition After CAR T-Cell Therapy for Chronic Lymphocytic Leukemia.

P. Hari, Bryon D Johnson, N. Shah, 2020, JCO oncology practice.

Combined immune checkpoint protein blockade and low dose whole body irradiation as immunotherapy for myeloma

J. Gershan, James J. Weber, Weiqing Jing, 2015, Journal of Immunotherapy for Cancer.

Programmed Death Receptor-1/Programmed Death Receptor Ligand-1 Blockade after Transient Lymphodepletion To Treat Myeloma

J. Gershan, Weiqing Jing, Tyce J. Kearl, 2013, The Journal of Immunology.

Tumor antigen analysis in neuroblastoma by serological interrogation of bioinformatic data

J. Khan, Qingrong Chen, R. Orentas, 2010, Cancer science.

A Phase 2 Study of Pembrolizumab during Lymphodepletion after Autologous Hematopoietic Cell Transplantation for Multiple Myeloma.

T. Braun, P. Hari, M. Pasquini, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Frontline Science: PECAM‐1 (CD31) expression in naïve and memory, but not acutely activated, CD8+ T cells

David M. Schauder, Bryon D Johnson, M. Riese, 2018, Journal of leukocyte biology.

Serum from mice immunized in the context of Treg inhibition identifies DEK as a neuroblastoma tumor antigen

J. Khan, Qingrong Chen, Bryon D Johnson, 2007, BMC Immunology.

Bispecific targeting of CD20 and CD19 increases polyfunctionality of chimeric antigen receptor T-cell products in B-cell malignancies.

P. Hari, D. Schneider, N. Shah, 2022, Cytotherapy.

Manufacturing Bispecific LV20.19 CAR T-Cells with IL-7 & IL-15 for a Shorter Duration Improves CAR T-Cell Immunophenotype While Maintaining Target Cell Dose

P. Hari, D. Schneider, N. Shah, 2021, Blood.

Single-Cell RNA Sequencing Identifies Expression Patterns Associated with Clinical Responses to Dual-Targeted CAR-T Cell Therapy

P. Hari, S. Malarkannan, D. Schneider, 2020 .

Use of Early Intrathecal Therapy to Manage High-Grade Immune Effector Cell-Associated Neurotoxicity Syndrome.

P. Hari, N. Shah, M. Hamadani, 2022, JAMA oncology.

Manufacturing chimeric antigen receptor T cells from cryopreserved peripheral blood cells: time for a collect-and-freeze model?

P. Hari, Bryon D Johnson, N. Shah, 2021, Cytotherapy.

Intrathecal chemotherapy for management of steroid-refractory CAR T-cell-associated neurotoxicity syndrome.

P. Hari, Bryon D Johnson, N. Shah, 2020, Blood advances.

Depletion of CD4 T cells enhances immunotherapy for neuroblastoma after syngeneic HSCT but compromises development of antitumor immune memory.

Bryon D Johnson, J. Gershan, Weiqing Jing, 2009, Blood.

Cancer Vaccines: Progress and Promise

R. Orentas, J. Hodge, Bryon D. Johnson, 2007 .

1 CANCER VACCINES : PROGRESS AND PROMISE

R. Orentas, J. Hodge, Bryon D. Johnson, 2007 .

T Cells Deficient in Diacylglycerol Kinase ζ Are Resistant to PD-1 Inhibition and Help Create Persistent Host Immunity to Leukemia.

M. Riese, J. Gershan, James J. Weber, 2017, Cancer research.

Immunosuppressive effects of multiple myeloma are overcome by PD-L1 blockade.

Weiqing Jing, W. Hallett, W. Drobyski, 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

PD-1 blockade after bispecific LV20.19 CAR T modulates CAR T-cell immunophenotype without meaningful clinical response

P. Hari, John M. Astle, N. Shah, 2021, Haematologica.

Bone Marrow-derived CD8+ T Cells From Pediatric Leukemia Patients Express PD1 and Expand Ex Vivo Following Induction Chemotherapy

M. Thakar, J. Gershan, Katie A. Palen, 2019, Journal of pediatric hematology/oncology.

Tracking ex vivo-expanded CD4+CD25+ and CD8+CD25+ regulatory T cells after infusion to prevent donor lymphocyte infusion-induced lethal acute graft-versus-host disease.

Bryon D Johnson, R. Truitt, G. Xia, 2004, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

The effect of tocilizumab on patient reported outcomes and inflammatory biomarkers in hematopoietic cell transplantation

Bryon D Johnson, C. Raison, S. Cole, 2022, Brain, behavior, & immunity - health.

Following Donor Leukocyte Infusion Therapy Suppression of Graft-Versus-Host Disease Role of Immunoregulatory Donor T Cells in

Bryon D Johnson, R. Truitt, J. LaBelle, 1999 .

Immune response modulation by curcumin in a latex allergy model

V. Kurup, Bryon D Johnson, J. Fink, 2007, Clinical and molecular allergy : CMA.

Inhibition of lung tumorigenesis by a small molecule CA170 targeting the immune checkpoint protein VISTA

R. Shoemaker, R. Lubet, Yian Wang, 2021, Communications Biology.

Synchronous effects of targeted mitochondrial complex I inhibitors on tumor and immune cells abrogate melanoma progression

Kathleen A. Boyle, B. Kalyanaraman, R. B. Hill, 2021, iScience.

Impact of Autologous Hematopoietic Cell Transplant (HCT) Followed By Dendritic Cell/Myeloma Fusion Vaccine with Lenalidomide Maintenance in Increasing Multiple Myeloma (MM) Immunity (BMT CTN 1401)

N. Geller, N. Munshi, M. Pasquini, 2021, Blood.